Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:3372-3380, 2006
DOI: 10.2337/db06-0002
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, J.
Right arrow Articles by Kurland, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, J.
Right arrow Articles by Kurland, I. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Decreased Hepatic Futile Cycling Compensates for Increased Glucose Disposal in the Pten Heterodeficient Mouse

Jun Xu1, Lori Gowen2, Christian Raphalides2, Katrina K. Hoyer3, Jason G. Weinger3, Mathilde Renard3, Joshua J. Troke3, Bhavapriya Vaitheesyaran1, W.N. Paul Lee4, Mohammed F. Saad5, Mark W. Sleeman2, Michael A. Teitell3,6, and Irwin J. Kurland1,7

1 Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York
2 Regeneron Pharmaceuticals, Tarrytown, New York
3 Department of Pathology, University of California Los Angeles, Los Angeles, California
4 Department of Pediatrics, Harbor-University of California Los Angeles Biomedical Institute, Torrance, California
5 Department of Preventive Medicine, State University of New York at Stony Brook, Stony Brook, New York
6 Molecular Biology Institute, University of California Los Angeles, Los Angeles, California
7 Departments of Pharmacological Sciences and Physiology and Biophysics, State University of New York at Stony Brook, Stony Brook, New York

Address correspondence and reprint requests to Irwin J. Kurland, SUNY at Stony Brook, HSC T-15 Room 060, Stony Brook, NY 11794-8154. E-mail: irwin.kurland{at}stonybrook.edu

Abbreviations: AUC, area under the curve; G6PDH, glucose-6-phosphate dehydrogenase; GC/MS, gas chromatography–mass spectrometry; glucose-6-P, glucose-6-phosphate; HGP, hepatic glucose production; HR-dGTT, hepatic recycling deuterated glucose tolerance test; HR-GTT, hepatic recycling glucose tolerance test; ipGTT, intraperitoneal glucose tolerance test; ITT, insulin tolerance test; PI3-K, phosphatidylinositol 3-kinase; PPAR, peroxisome proliferator–activated receptor; PTEN, phosphatase and tensin homolog deleted on chromosome 10; TCA, trichloroacetic acid

Despite altered regulation of insulin signaling, Pten+/– heterodeficient standard diet–fed mice, ~4 months old, exhibit normal fasting glucose and insulin levels. We report here a stable isotope flux phenotyping study of this "silent" phenotype, in which tissue-specific insulin effects in whole-body Pten+/–-deficient mice were dissected in vivo. Flux phenotyping showed gain of function in Pten+/– mice, seen as increased peripheral glucose disposal, and compensation by a metabolic feedback mechanism that 1) decreases hepatic glucose recycling via suppression of glucokinase expression in the basal state to preserve hepatic glucose production and 2) increases hepatic responsiveness in the fasted-to-fed transition. In Pten+/– mice, hepatic gene expression of glucokinase was 10-fold less than wild-type (Pten+/+) mice in the fasted state and reached Pten+/+ values in the fed state. Glucose-6-phosphatase expression was the same for Pten+/– and Pten+/+ mice in the fasted state, and its expression for Pten+/– was 25% of Pten+/+ in the fed state. This study demonstrates how intra- and interorgan flux compensations can preserve glucose homeostasis (despite a specific gene defect that accelerates glucose disposal) and how flux phenotyping can dissect these tissue-specific flux compensations in mice presenting with a "silent" phenotype.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.